Cellect Biotechnology Ltd Stock News

Companies In The News Are:

Cellect Biotechnology Ltd. (APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced the agreement by several investors to exercise certain war

Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today announced the publication of an article in Bone Marrow Trans

TEL AVIV, Israel , April 27, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, received an

Axsome Therapeutics (NASDAQ:AXSM) +44% as Axsome's lead candidate successful in Alzheimer's study.Avadel Pharmaceuticals plc (NASDAQ:AVDL) +34% on positive data on lead drug.Yield10 Bioscience (NA

CELLECT BIOTECH/S (NASDAQ:APOP) and Cryolife (NYSE:CRY) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their inst

Cellect Biotechnology Ltd. (Nasdaq: APOP), a developer of a novel stem cell production technology, today announced operating and financial results for the fourth quarter and full year ended December 3

ION Geophysical (NYSE:IO) +120% on expecting big jump in Q1 revenues.Neptune Wellness Solutions (NASDAQ:NEPT) +47% on receiving health Canada authorization to commercialize natural, plant-based hand

Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, received an official communication from the China National Intelle

Meet Canndoc: A Fly exclusive interview with Intercure CEO Alex Rabinovitch APOP TLRY

CELLECT BIOTECH/S (NASDAQ:APOP) and Irhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) * Masimo Corporation (NASDAQ: MASI)Down In The Dum

InterCure (TASE: INCR) announces today that wholly owned subsidiary, Canndoc, has entered into a strategic partnership agreement with Super-Pharm, Israel's leading and largest drugstore chain. Under t

NeuroMetrix (NASDAQ:NURO) -18%.Guidewire Software (NYSE:GWRE) -14% on Q2 earnings.VBI Vaccines (NASDAQ:VBIV) -11% on FY earnings.Cellect Biotechnology (NASDAQ:APOP) -12%.Eros International (NYSE:E

Gainers Cellect Biotechnology Ltd. (NASDAQ: APOP) shares jumped 45% to close at $3.03 on Wednesday. Cellect Biotechnology and Canndoc Ltd. agreed to enter into strategic pharma...